Mechanical thromboprophylaxis would suffice after total knee arthroplasties in Asian patients?
- 57 Downloads
Our prospective study evaluated the incidence and location of deep vein thrombosis (DVT), the risk factors for PE and the natural history of DVT after TKA in patients who have received only mechanical compression device without having any chemical thromboprophylaxis or therapeutic treatment.
We studied 408 consecutive patients (691 knees) who underwent primary TKA; 283 patients had one-stage bilateral TKAs and 125 had unilateral TKAs. Coagulation assays, the full blood count and blood typing tests, and serum chemical profiles were undertaken in all patients on three separate occasions. Molecular genetic testing was performed preoperatively to detect the genetic traits involving DVT. Bilateral simultaneous or unilateral venograms were carried out at 6 or 7 days after operation. Perfusion lung scanning was undertaken before and at 7 or 8 days after operation.
In the 691 venograms in 408 patients, only 4 knees (0.6%) were positive for fresh thrombi. In the 4 knees with DVT, thrombi were located in the calf veins. We observed factor V Leiden mutation, antithrombin-III level, and prothrombin promoter G20210A mutation were absent in all patients. We saw no relationship between DVT and coagulation or thrombophilic data. No pulmonary embolism (PE) occurred as shown by negative perfusion lung scan and absence of symptoms.
We concluded that the combinations of absent thrombophilic polymorphisms with low clinical prothrombotic risk factors led to low prevalence of DVT and virtually absent PE after TKA in the current series of patients, who had received mechanical compression device only without chemical thromboprophylaxis.
KeywordsPrevalence deep vein thrombosis Pulmonary embolism Total knee arthroplasty Chemical thromboprophylaxis Mechanical compression device
There is no funding source.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article contains studies with human participants or animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 3.Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, Ortel TL, Pauker SG, Colwell CW Jr. (2012) Prevention of VTE in orthopedic surgery patients: antithrombotic, therapy and prevention of thrombosis, 9th edition: American College of chest physicians Evidence-based Clinical Practice Guidelines. Chest 141:e278SCrossRefGoogle Scholar
- 8.Lewis CG, Inneh IA, Schutzer SF, Grady-Benson J (2014) Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from single institution. J Bone Joint Surg Am 96:1327CrossRefGoogle Scholar
- 12.Sakai T, Izumi M, Kumagai K, Kidera K, Yamaguchi T, Asahara T, Kozuru H, Jiuchi Y, Mawatari M, Osaki M, Motokawa S, Migita K (2016) Effects of a foot pump on the incidence of deep vein thrombosis after total knee arthroplasty in patients given edoxaban. A randomized controlled study. Medicine 95:e2247CrossRefGoogle Scholar
- 22.Nagase Y, Yasunaga H, Horiguchi H, Hashimoto H, Shoda N, Kadono Y, Matsuda S, Nakamura K, Tanaka S (2011) Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. J Bone Joint Surg Am 93:e146CrossRefGoogle Scholar